Crown Bioscience News Today

Crown Bioscience, a JSR Life Sciences company, this time announces the completion of a global collaboration agreement with the Shanghai Model Organism Center . This agreement extends...

Biomarker Discovery Outsourcing Service MarketThe Biomarker Discovery Outsourcing Service Market is estimated to be worth US$ 13.3 billion in 2024 and is projected to be valued at US$ 41.4 billion in 2034. Between 2024 and 2034, the industry is expected to register a CAGR of 12.2%.The increasing demand for personali...

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The

Crown Biosciences Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

Preclinical Assets Market Analysis and Future Prospects for 2030

The global oncology-based in-vivo CRO market is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033.The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along with 10 Million fatalities. This a...

Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidXploreTM.

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The